Course: Specialization in Methodology and Ethics of Oncological Clinical Trials (European Institute of Oncology): Difference between revisions
m (Update categories.) |
m (Update categories.) |
||
| Line 113: | Line 113: | ||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | ||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | <span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | ||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
Revision as of 12:05, 6 December 2025
Go back to European Institute of Oncology page
Primary purpose: To equip professionals and researchers with methodological, regulatory, and bioethical knowledge necessary to conduct clinical trials, particularly in oncology.
Target audience: Oncologists or specializing in oncology, investigators, research nurses, healthcare professionals, data managers, monitors, biologists and biotechnologists researchers, bioinformatics and biostatisticians, clinical and research psychologists, bioethicists, biolaw experts, medical examiners, medical humanities researchers.
Cancer areas of interest: C00-C97: All cancer types. Click here to learn more.
Information: Click here to access.
